Dr. Malone Warns of Immune Imprinting After Fauci Floats

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
642
Dr. Malone Warns of Immune Imprinting After Fauci Floats 2nd Booster Shots

Dr. Robert Malone is warning of immune imprinting after Dr. Anthony Fauci signaled his backing for second COVID-19 vaccine boosters for all Americans aged 5 and older.

“I couldn’t design a vaccine if I wanted to, to be more likely to drive immune imprinting,” Malone, who helped invent the messenger RNA technology the Pfizer and Moderna vaccines are built on, told The Epoch Times.

Immune imprinting refers to a phenomenon whereby initial exposure to a virus strain may prevent the body from producing enough neutralizing antibodies against a new viral strain.

The COVID-19 vaccines currently in circulation are based on the Wuhan strain of the CCP (Chinese Communist Party) virus. Also known as SARS-CoV-2, the virus causes COVID-19.

A number of strains have emerged and become dominant since the Wuhan strain was prevalent, including the currently dominant Omicron variant.

Researchers from Imperial College London and the United Kingdom Health Security Agency have found that people who received three doses of a COVID-19 vaccine and were infected with the Wuhan strain had a lower level of protection against later strains when compared to people who hadn’t been infected.

Other groups, including researchers at the Beth Israel Deaconess Medical Center, have found the vaccines to be much less effective against Omicron subvariants than the Wuhan strain.

A number of studies have found negative effectiveness among vaccinated groups. That means those who get vaccinated are more likely to become infected.

In some areas, vaccinated persons account for a majority of those infected or in hospitals or dying with COVID-19. In Louisiana, for example, 70 percent of the deaths recorded between June 23 and 29 were among the vaccinated .

Second Booster Push

The vaccines were originally promoted as two-shot primary regimens (Pfizer and Moderna) or a one-shot immunization (Johnson & Johnson). They were said to have an efficacy as high as 100 percent against symptomatic infection.

Due to waning effectiveness against the emerging variants, U.S. officials authorized booster doses. In March, because the effects of the boosters against infection didn’t last long, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) cleared and recommended second boosters for all adults older than age 50.

Fauci, the head of the National Institute of Allergy and Infectious Diseases and President Joe Biden’s top medical adviser, is now saying Americans aged 5 to 50 should be allowed to get a second booster dose.

Fauci told The Washington Post that the United States “[needs] to allow people who are under 50 to get their second booster shot, since it may have been months since many of them got their first booster.”

“If I got my third shot [in 2021], it is very likely the immunity is waning,” he said.

Fauci, who has no authority over authorizing or recommending boosters, has signaled major changes to U.S. vaccine policy in the past.

White House, FDA Respond

Dr. Ashish Jha, the White House’s COVID-19 response coordinator, told reporters on July 12, “We have conversations all the time about what are possible things we could be doing to better protect the American people.”

Jha said that the decision on second boosters will be made by the FDA and CDC. Fauci uttered a similar statement during the briefing.

“The FDA is evaluating the current situation, including the emerging epidemiology indicating increased hospitalization, and will be open to all potential options to address this, if necessary,” an FDA spokesperson told The Epoch Times in an email.

Vaccine makers and the FDA are working together to develop variant-specific shots for the fall, which, they say, will offer better protection. But the updated shots aren’t yet on the market.

Many U.S. adults have received a primary series of a vaccine, including 91 percent of those aged 65 and older and 77 percent of those aged 18 and older. But booster doses have been a harder sell. Only 70 percent of elderly persons who received a primary series have received a first booster, along with just 51 percent of those aged 18 and older, according to CDC data. A second booster has only been administered to 28 percent of the population aged 50 and older.

Few of the COVID-19 vaccine mandates included a booster, and most of the mandates have been rescinded due to factors such as plunging COVID-19 metrics and the waning effectiveness of the vaccines.

‘Vaccine-Driven Disease’

The COVID-19 metrics in the United States have been creeping up in recent weeks, with the weekly average number of cases jumping by 75 percent since late March and hospitalizations with COVID-19 doubling since April.

Officials blame the new BA.4 and BA.5 Omicron subvariants, which have been edging out other strains in the United States and are thought to be more transmissible but don’t seem to cause more severe illness. The subvariants are “more likely to lead to vaccine breakthrough infections,” researchers at Columbia University found.

People should get a booster as soon as they’re eligible, which is typically about five months after their last shot, Jha and CDC Director Rochelle Walensky said.

“Don’t delay,” Jha said.

But Malone is among the scientists who are challenging the idea that the old vaccines are the solution.

“You got a major problem with the new Omicron, that’s the BA.5. The people that are getting infected chronically and hospitalized and dying are predominantly the vaccinated. It’s happening all over the world,” Malone said.

“Now they’ve got a problem because they have driven this because of immune imprinting. This is increasingly becoming a vaccine-driven disease.”

Malone said that Fauci, a major vaccine proponent, “has basically created a situation through the insistence on the hyper vaccination where he’s actually driving the disease in the United States.”

Government officials disagree. Walensky said CDC data show that people who either haven’t received a vaccine or haven’t been boosted have less protection than those who have been boosted, including against infection, even as studies show the boost against infection quickly drops after the first and second booster.

Fauci said that people who were previously infected, or have natural immunity from surviving COVID-19, “don’t have a lot of protection” against the new subvariants.

Neither mentioned how natural immunity, according to a new study, remains stronger than the protection from vaccines, even with boosters, particularly against severe disease.

https://www.theepochtimes.com/edition/special...hiTwX%2Fpf
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 497

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 264

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 414

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 452

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 298

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 477

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 368

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Verona Pharma Hits New Stock High Amid Strong Performance

Updated Category News Views 221

Verona Pharma Achieves Record Stock Price Milestone Verona Pharma PLC (NASDAQ: VRNA) has recently reached a remarkable milestone, with its stock price soaring to an all-time high of $49.05. This achievement highlights the company’s impressive growth trajectory and resilience in the biopharmaceutical sector, particularly in addressing respiratory diseases. Impressive...

Continue Reading
Foresight Ventures VCT PLC Announces Successful AGM Outcomes

Updated Category News Views 133

Exciting Developments from the AGM of Foresight Ventures VCT PLC FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 During the recent Annual General Meeting, Foresight Ventures VCT plc showcased a remarkable turnout in terms of shareholder engagement, underscoring the company’s commitment to transparency and active participation in governance. Key Resolutions Passed...

Continue Reading
Diego Lopes Shines with TKO Victory Over Jean Silva at Noche UFC

Updated Category News Views 355

Diego Lopes Triumphs in a Thrilling TKO Victory at Noche UFC In an electrifying match, Diego Lopes made headlines by defeating Jean Silva at the Noche UFC event. Lopes, a talented 30-year-old Brazilian fighter, displayed exceptional skill and resilience, clinching a TKO victory in the second round of the Featherweight bout. A Historic Night in Mixed Martial Arts This...

Continue Reading
Exploring Tech Stocks with High Potential Gains Ahead

Updated Category News Views 204

Cryptocurrency Market Analysis In the past year, numerous cryptocurrencies have seen a surge as investors anticipated a decrease in interest rates, prompting a return to speculative investments. Significant events, such as the approval of the first spot price exchange-traded funds (ETFs) for Bitcoin and Ether, Ripple's favorable ruling against the U.S. Securities and...

Continue Reading
OxygenIT Launches Free GreenOps Platform to Transform Cloud Carbon Footprint

Updated Category News Views 205

Transforming Cloud Carbon Management with GreenOps In a groundbreaking initiative, OxygenIT has introduced its GreenOps platform, providing organizations with a free and comprehensive tool designed to eliminate the guesswork involved in calculating cloud carbon footprints. This innovative approach seeks to empower businesses of any size to replace unreliable manual...

Continue Reading